Covered recipient · General Payments record
BRIAN K JEFFERSON
Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2024 · Entire year
$130,487.01
135 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2024 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63,250.00 | 19 |
| Compensation for serving as faculty or as a speaker for a medical education program | $37,500.00 | 9 |
| Travel and Lodging | $14,185.16 | 35 |
| Consulting Fee | $9,712.50 | 9 |
| Food and Beverage | $5,617.24 | 62 |
| Grant | $222.11 | 1 |
By paying entity
PY2024 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boston Scientific Corporation | $74,785.80 | 74 |
| ShockWave Medical, Inc | $45,062.32 | 35 |
| Penumbra, Inc. | $3,348.57 | 4 |
| Abbott Laboratories | $2,823.61 | 4 |
| PROCYRION, INC. | $2,025.00 | 1 |
| ABIOMED | $1,190.38 | 5 |
| Janssen Scientific Affairs, LLC | $750.00 | 1 |
| Recor Medical Inc | $179.27 | 1 |
| ASAHI INTECC USA, INC. | $120.37 | 2 |
| ASAHI INTECC CO., LTD. | $60.47 | 1 |
| CARDIVA MEDICAL, INC. | $38.51 | 2 |
| PFIZER INC. | $33.53 | 2 |
| Daiichi Sankyo Inc. | $26.91 | 1 |
| Novo Nordisk Inc | $21.49 | 1 |
| Kiniksa Pharmaceuticals International, plc | $20.78 | 1 |
Page 3 of 3; records 101–135 of 135 matching records. This page contains 35 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
BRIAN K JEFFERSON
NPI 1508830407 · CMS profile ID 23067
Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology
NASHVILLE, TN
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 3 of 3; records 101–135 of 135 matching records. This page contains 35 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1508830407?year=2024&recipient=provider&page=3#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- BRIAN K JEFFERSON, NPI 1508830407, CMS profile ID 23067. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–135 of 135 matching records. This page contains 35 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508830407?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- APA 7
- IndustryPayments. (2026). BRIAN K JEFFERSON, NPI 1508830407, CMS profile ID 23067. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–135 of 135 matching records. This page contains 35 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508830407?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- Bluebook
- BRIAN K JEFFERSON, NPI 1508830407, CMS profile ID 23067, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–135 of 135 matching records. This page contains 35 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1508830407?year=2024&recipient=provider&page=3#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2024
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30
135 matching records · $130,487.01 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 101–135 of 135.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | $53.68 | 04/17/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461556 | CMS |
| Boston Scientific Corporation | $68.15 | 04/17/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461560 | CMS |
| Boston Scientific Corporation | $144.03 | 04/16/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461586 | CMS |
| Penumbra, Inc. | $125.79 | 04/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1076214300 | CMS |
| ShockWave Medical, Inc | $41.08 | 04/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1152982454 | CMS |
| ShockWave Medical, Inc | $97.66 | 04/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1152983156 | CMS |
| Boston Scientific Corporation | $625.00 | 04/12/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461444 | CMS |
| Boston Scientific Corporation | $2,500.00 | 04/12/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461512 | CMS |
| Penumbra, Inc. | $36.11 | 04/12/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1076230658 | CMS |
| Penumbra, Inc. | $186.67 | 04/12/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1076231270 | CMS |
| ShockWave Medical, Inc | $304.51 | 04/12/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1152976287 | CMS |
| Boston Scientific Corporation | $18.00 | 04/08/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461492 | CMS |
| ShockWave Medical, Inc | $3,750.00 | 04/08/2024 | Compensation for serving as faculty or as a speaker for a medical education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006698 | CMS |
| ABIOMED | $140.51 | 04/04/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1142222558 | CMS |
| ShockWave Medical, Inc | $3,750.00 | 03/28/2024 | Compensation for serving as faculty or as a speaker for a medical education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006694 | CMS |
| ShockWave Medical, Inc | $151.42 | 03/25/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006660 | CMS |
| ShockWave Medical, Inc | $287.02 | 03/25/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006662 | CMS |
| ShockWave Medical, Inc | $4,500.00 | 03/21/2024 | Compensation for serving as faculty or as a speaker for a medical education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006696 | CMS |
| Boston Scientific Corporation | $937.50 | 03/15/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461464 | CMS |
| Boston Scientific Corporation | $625.00 | 03/08/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461442 | CMS |
| Boston Scientific Corporation | $132.87 | 03/06/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461580 | CMS |
| Boston Scientific Corporation | $194.96 | 02/24/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461602 | CMS |
| Boston Scientific Corporation | $333.60 | 02/24/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461616 | CMS |
| Boston Scientific Corporation | $75.02 | 02/23/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461564 | CMS |
| Boston Scientific Corporation | $147.46 | 02/23/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461594 | CMS |
| Boston Scientific Corporation | $168.24 | 02/23/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461596 | CMS |
| Boston Scientific Corporation | $205.90 | 02/23/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092461606 | CMS |
| CARDIVA MEDICAL, INC. | $22.34 | 02/15/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1143856421 | CMS |
| Janssen Scientific Affairs, LLC | $750.00 | 02/08/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1078862481 | CMS |
| ShockWave Medical, Inc | $21.51 | 01/25/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1152974428 | CMS |
| ShockWave Medical, Inc | $102.92 | 01/25/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006656 | CMS |
| ShockWave Medical, Inc | $1,305.28 | 01/25/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1153006658 | CMS |
| ABIOMED | $385.43 | 01/17/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1142222634 | CMS |
| ABIOMED | $595.09 | 01/17/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1142222636 | CMS |
| ABIOMED | $45.00 | 01/17/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1142222644 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $383,399.60 | 61 |
| PY2024 | Principal investigator | $220,037.63 | 42 |
| PY2023 | Principal investigator | $84,546.59 | 29 |
| PY2022 | Principal investigator | $91,834.65 | 21 |
| PY2021 | Principal investigator | $145,534.51 | 31 |
| PY2020 | Principal investigator | $348,567.34 | 33 |
| PY2019 | Principal investigator | $254,519.43 | 41 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
61 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Medtronic, Inc. | $25,974.64 | 12/31/2025 | Non-covered Recipient Entity Scri Cardiovascular | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1185006279 |
| Principal investigator 1 | Medtronic, Inc. | $3,250.00 | 12/26/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1192325473 |
| Principal investigator 1 | Medtronic, Inc. | $3,250.00 | 12/26/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1192325475 |
| Principal investigator 1 | Boston Scientific Corporation | $52,860.00 | 12/09/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577347 |
| Principal investigator 1 | Shockwave Medical, Inc | $392.90 | 12/03/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055634 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $747.00 | 11/19/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507400 |
| Principal investigator 1 | Medtronic, Inc. | $3,250.00 | 11/05/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1192325471 |
| Principal investigator 1 | Boston Scientific Corporation | $2,106.00 | 11/04/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577345 |
| Principal investigator 1 | Shockwave Medical, Inc | $2,996.63 | 10/29/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055683 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,150.00 | 10/24/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507398 |
| Principal investigator 1 | Shockwave Medical, Inc | $3,820.00 | 10/20/2025 | Covered Recipient Teaching Hospital Tristar Centennial Medical Center | Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II | No dispute reported | 06/30/2026 | 1175055533 |
| Principal investigator 1 | Shockwave Medical, Inc | $13,010.22 | 10/16/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055674 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,750.00 | 10/10/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507382 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,500.00 | 10/10/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507388 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $2,500.00 | 10/10/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507392 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,500.00 | 10/10/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507394 |
| Principal investigator 1 | Boston Scientific Corporation | $3,577.50 | 10/07/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577129 |
| Principal investigator 1 | Medtronic, Inc. | $1,408.00 | 09/25/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1192325469 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507364 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507368 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507370 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507372 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507374 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,000.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507376 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507378 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507380 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507576 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507580 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $250.00 | 09/16/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507582 |
| Principal investigator 1 | Shockwave Medical, Inc | $4,179.76 | 09/12/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055664 |
| Principal investigator 1 | Boston Scientific Corporation | $4,347.00 | 09/09/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577125 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,020.00 | 08/18/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507584 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $19,570.00 | 08/18/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507586 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,000.00 | 08/14/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507358 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $9,650.00 | 08/14/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507360 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,000.00 | 08/14/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507362 |
| Principal investigator 1 | Boston Scientific Corporation | $2,808.00 | 08/05/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577127 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $5,080.00 | 07/28/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507570 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,215.00 | 07/28/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507572 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,215.00 | 07/28/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507574 |
| Principal investigator 1 | Shockwave Medical, Inc | $3,000.00 | 07/17/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055646 |
| Principal investigator 1 | Shockwave Medical, Inc | $500.00 | 07/17/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055654 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $4,725.00 | 07/14/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507356 |
| Principal investigator 1 | Boston Scientific Corporation | $2,221.00 | 07/08/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577123 |
| Principal investigator 1 | Medtronic, Inc. | $93,031.00 | 06/30/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1192325467 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,000.00 | 06/13/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507682 |
| Principal investigator 1 | Shockwave Medical, Inc | $10,700.00 | 06/03/2025 | Non-covered Recipient Entity Centennial Heart | Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study) | No dispute reported | 06/30/2026 | 1175055695 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $15,000.00 | 05/07/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507698 |
| Principal investigator 1 | Boston Scientific Corporation | $250.00 | 05/06/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577121 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $1,595.00 | 04/23/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507680 |
| Principal investigator 1 | Boston Scientific Corporation | $769.50 | 04/08/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577119 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $3,600.00 | 03/26/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507694 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $21,070.00 | 03/26/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis | No dispute reported | 06/30/2026 | 1237507696 |
| Principal investigator 1 | Medtronic, Inc. | $70.00 | 03/20/2025 | Non-covered Recipient Entity Hca Research Institute Llc | SPYRAL HTN-ON MED Expan | No dispute reported | 06/30/2026 | 1192317896 |
| Principal investigator 1 | Boston Scientific Corporation | $1,539.00 | 03/11/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577117 |
| Principal investigator 1 | Boston Scientific Corporation | $1,336.50 | 02/11/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577115 |
| Principal investigator 1 | Medtronic, Inc. | $29.00 | 02/04/2025 | Covered Recipient Teaching Hospital Tristar Centennial Medical Center | SPYRAL AFFIRM | No dispute reported | 06/30/2026 | 1185006239 |
| Principal investigator 1 | Philips North America LLC | $2,665.00 | 02/03/2025 | Non-covered Recipient Entity HCA Research Institute LLC | Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS) | No dispute reported | 06/30/2026 | 1232579069 |
| Principal investigator 1 | M.A. Med Alliance S.A. | $13,125.00 | 01/31/2025 | Non-covered Recipient Entity HCA Research Insitute LLC | A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 PTCA Drug Eluting Balloon in the Treatment of Subjects With De Novo Coronary Lesions in Small Vessels | No dispute reported | 06/30/2026 | 1237507678 |
| Principal investigator 1 | Boston Scientific Corporation | $6,508.35 | 01/28/2025 | Non-covered Recipient Entity HCA RESEARCH INSTITUTE LLC | AGENT IDE | No dispute reported | 06/30/2026 | 1207577113 |
| Principal investigator 1 | Abbott Laboratories | $9,037.60 | 01/10/2025 | Non-covered Recipient Entity Sarah Cannon Research Institute LLC | ECLIPSE | No dispute reported | 06/30/2026 | 1233993308 |